FdaApplication
ANDA 207240
Identifiers
- fda_app_no: ANDA207240
Properties
| Property | Value |
|---|---|
| applicant_name | SCIEGEN PHARMACEUTICALS INC |
| application_type | ANDA |
| approval_date | 2018-04-18 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ARIPIPRAZOLE | ARIPIPRAZOLE | 15MG | TABLET, ORALLY DISINTEGRATING;ORAL |
| ARIPIPRAZOLE | ARIPIPRAZOLE | 10MG | TABLET, ORALLY DISINTEGRATING;ORAL |
2 products